Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study.
Breast Cancer Res Treat. 2019 Feb;174(1):187-196. doi: 10.1007/s10549-018-5058-6. Epub 2018 Nov 30.
Breast Cancer Res Treat. 2019.
PMID: 30506110
Free PMC article.
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer.
Barrios CH, Saji S, Harbeck N, Zhang H, Jung KH, Patel S, Patel S, Duc AN, Liste-Hermoso M, Chui SY, Mittendorf EA.
Barrios CH, et al. Among authors: liste hermoso m.
NPJ Breast Cancer. 2022 Sep 19;8(1):108. doi: 10.1038/s41523-022-00457-3.
NPJ Breast Cancer. 2022.
PMID: 36123366
Free PMC article.
Item in Clipboard
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
Mittendorf EA, Zhang H, Barrios CH, Saji S, Jung KH, Hegg R, Koehler A, Sohn J, Iwata H, Telli ML, Ferrario C, Punie K, Penault-Llorca F, Patel S, Duc AN, Liste-Hermoso M, Maiya V, Molinero L, Chui SY, Harbeck N.
Mittendorf EA, et al. Among authors: liste hermoso m.
Lancet. 2020 Oct 10;396(10257):1090-1100. doi: 10.1016/S0140-6736(20)31953-X. Epub 2020 Sep 20.
Lancet. 2020.
PMID: 32966830
Clinical Trial.
Item in Clipboard
Cite
Cite